Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials
Children · 01.03.2024 · 11 (3) · 296
DOI: 10.3390/children11030296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Children, online erschienen am 01.03.2024. Verfasst von Sara María Fernández-González und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Gastroenterology, Hepatology and Nutrition Unit, Department of Pediatrics, A Coruña University Hospital, Area Sanitaria A Coruña-Cee, 15006…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Professor Novoa Santos Foundation.
Abstract (Originalsprache)
This systematic review was conducted with the objective of understanding the efficacy and safety of proton pump inhibitors (PPIs) in the pediatric population. We used PubMed to identify randomized controlled trials (RCTs) published between 1 June 2010 and 30 June 2023, performed in patients from birth to 18 years old with gastroesophageal reflux disease (GERD) who received treatment with any PPI. This literature search yielded 76 articles and 13 of these met the inclusion criteria. For infants, PPIs were equal to placebos in reducing GERD symptoms in four articles. In one article, the numbers of GER episodes and esophageal acid exposures were lower in infants who received PPIs in the left lateral position, but there was generally no significant improvement in symptoms. In another publication, the combination of PPIs and feeding modifications (FMs) was not more effective than PPIs alone. For children and adolescents, PPIs were effective in improving symptoms and achieving endoscopic healing, which was subsequently maintained. To conclude, PPIs are not effective in reducing the symptoms related to GERD in infants but are effective in older children, where histological remission can be seen. Generally, PPIs are well tolerated, but it is important to remember the possible adverse events (AEs), especially if PPIs are used for an extended period.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Gastroenterology, Hepatology and Nutrition Unit, Department of Pediatrics, A Coruña University Hospital, Area Sanitaria A Coruña-Cee, 15006 A Coruña, Spain.
ORCID-Profile: Sara María Fernández-González, Ana Moreno-Álvarez, Alfonso Solar-Boga
Förderung
- Professor Novoa Santos Foundation
Zitieren
APA
Fernández-González, S. M., Moreno-Álvarez, A., & Solar-Boga, A. (2024). Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials. Children, 11(3), 296. https://doi.org/10.3390/children11030296
Vancouver
Fernández-González SM, Moreno-Álvarez A, Solar-Boga A. Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials. Children. 2024;11(3):296. doi:10.3390/children11030296
BibTeX
@article{FernndezGonzlez2024,
author = {Fernández-González, Sara María and Moreno-Álvarez, Ana and Solar-Boga, Alfonso},
title = {Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials},
journal = {Children},
year = {2024},
volume = {11},
number = {3},
pages = {296},
doi = {10.3390/children11030296}
}
EUVIMED